Story perspectives

Anthropic Opens San Francisco Wet Lab for Drug Discovery

By Drooid · Sep 18, 2026, 6:32 PM UTC · How we work

Summary

Anthropic Opens Wet Lab

Anthropic opened a wet lab in San Francisco Bay Area to conduct biological experiments.
Eric Kauderer-Abrams, head of Life Sciences, says Anthropic runs experiments in-house and with partners.
Claude will direct lab robots, reducing labor and following the Model Hardware Protocol launched August 2026, human oversight essential.
Initial drug-discovery will target preclinical research on neglected and orphan diseases.
Anthropic will refine Claude with lab data while adhering to strict biosafety rules.

Summary

Anthropic Flags Weaponization

Anthropic researchers warned AI could trigger human extinction within weeks after internal discussions.
CEO Dario Amodei published a September 12 essay urging a slowdown of AI development because of catastrophic risks.
Anthropic disclosed that its systems might be repurposed for biological weapons, sparking external skepticism.
The firm set a boundary against running clinical trials, focusing on preclinical work to avoid direct competition.

History

Historical Context

In December 2018 DeepMind’s AlphaFold topped CASP13, delivering the most accurate structures for 25 of 43 hard targets and a median GDT score well above rivals. AlphaFold 2 later achieved a 92-plus median GDT at CASP14 in November 2020 and released an open database that accelerated drug discovery. Anthropic now applies this AI-biology model in its San Francisco wet lab, drawing regulator attention such as the FDA.

1 of 3

Anthropic Opens Wet Lab

Anthropic opened a wet lab in San Francisco Bay Area to conduct biological experiments.
Eric Kauderer-Abrams, head of Life Sciences, says Anthropic runs experiments in-house and with partners.
Claude will direct lab robots, reducing labor and following the Model Hardware Protocol launched August 2026, human oversight essential.
Initial drug-discovery will target preclinical research on neglected and orphan diseases.
Anthropic will refine Claude with lab data while adhering to strict biosafety rules.

1 / 3